Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALGN Align Technology	$194.28 +2.6%	$180.92	$141.74 ▼ $263.24	$13.72B	1.63	912,773 shs	761,178 shs
ENOV Enovis	$32.99 +5.2%	$33.05	$28.83 ▼ $49.83	$1.79B	1.7	886,445 shs	1.27 million shs
SNN Smith & Nephew SNATS	$30.59 -0.1%	$28.77	$23.69 ▼ $31.72	$13.42B	0.69	816,375 shs	789,975 shs
WILYY Demant A/S	$21.31	$19.57	$15.03 ▼ $21.96	$9.11B	0.98	211 shs	8 shs

Beginner's Guide To Retirement Stocks

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALGN Align Technology	+0.43%	+3.22%	+4.75%	+19.77%	-21.58%
ENOV Enovis	-1.32%	+4.51%	+0.13%	-15.49%	-30.62%
SNN Smith & Nephew SNATS	+1.41%	+5.16%	+5.90%	+8.91%	+23.77%
WILYY Demant A/S	0.00%	0.00%	+5.47%	+17.06%	+0.54%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALGN Align Technology	4.6174 of 5 stars	3.3	4.0	0.0	3.8	3.5	1.7	1.3
ENOV Enovis	3.428 of 5 stars	3.4	3.0	0.0	0.0	2.7	1.7	1.9
SNN Smith & Nephew SNATS	3.7108 of 5 stars	1.0	5.0	2.5	0.0	3.3	0.0	4.4
WILYY Demant A/S	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALGN Align Technology	2.67	Moderate Buy	$241.25	24.18% Upside
ENOV Enovis	2.80	Moderate Buy	$58.00	75.81% Upside
SNN Smith & Nephew SNATS	2.00	Hold	$28.00	-8.47% Downside
WILYY Demant A/S	3.20	Buy	N/A	N/A

Current Analyst Ratings Breakdown

Latest WILYY, SNN, ENOV, and ALGN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/20/2025	WILYY Demant A/S	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
6/5/2025	WILYY Demant A/S	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
5/14/2025	ENOV Enovis	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$75.00 ➝ $70.00
5/9/2025	ENOV Enovis	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Outperform ➝ Market Outperform	$62.00 ➝ $55.00
5/9/2025	ENOV Enovis	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$64.00 ➝ $57.00
5/1/2025	ALGN Align Technology	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$255.00 ➝ $246.00
5/1/2025	ALGN Align Technology	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$235.00 ➝ $250.00
5/1/2025	ALGN Align Technology	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$165.00 ➝ $200.00
5/1/2025	ALGN Align Technology	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
5/1/2025	SNN Smith & Nephew SNATS	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$27.00 ➝ $28.00
4/29/2025	ALGN Align Technology	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$250.00 ➝ $245.00

(Data available from 7/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALGN Align Technology	$4.00B	3.52	$9.23 per share	21.06	$51.60 per share	3.77
ENOV Enovis	$2.11B	0.89	$20.24 per share	1.63	$45.10 per share	0.73
SNN Smith & Nephew SNATS	$5.81B	2.31	$3.15 per share	9.70	$12.04 per share	2.54
WILYY Demant A/S	$3.25B	2.80	$0.95 per share	22.46	$3.16 per share	6.74

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALGN Align Technology	$421.36M	$5.49	35.39	21.71	2.01	10.29%	13.52%	8.36%	7/23/2025 (Estimated)
ENOV Enovis	-$825.49M	-$13.95	N/A	10.34	N/A	-37.65%	5.99%	3.44%	8/6/2025 (Estimated)
SNN Smith & Nephew SNATS	$412M	$2.16	14.16	15.30	0.94	N/A	N/A	N/A	8/5/2025 (Estimated)
WILYY Demant A/S	$346.11M	N/A	0.00	18.69	N/A	N/A	N/A	N/A	8/12/2025 (Estimated)

Latest WILYY, SNN, ENOV, and ALGN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/23/2025	Q2 2025	ALGN Align Technology	$2.57	N/A	N/A	N/A	N/A	N/A
5/8/2025	Q1 2025	ENOV Enovis	$0.74	$0.81	+$0.07	-$0.98	$558.80 million	$558.83 million
4/30/2025	Q1 2025	ALGN Align Technology	$2.00	$2.13	+$0.13	$1.27	$977.90 million	$979.26 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALGN Align Technology	N/A	N/A	N/A	N/A	N/A
ENOV Enovis	N/A	N/A	N/A	N/A	N/A
SNN Smith & Nephew SNATS	$0.89	2.91%	N/A	41.20%	N/A
WILYY Demant A/S	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALGN Align Technology	N/A	1.21	1.08
ENOV Enovis	0.52	2.55	1.32
SNN Smith & Nephew SNATS	0.62	2.89	1.33
WILYY Demant A/S	1.29	1.63	1.22

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALGN Align Technology	88.43%
ENOV Enovis	98.45%
SNN Smith & Nephew SNATS	25.64%
WILYY Demant A/S	N/A

Insider Ownership

Company	Insider Ownership
ALGN Align Technology	0.66%
ENOV Enovis	2.70%
SNN Smith & Nephew SNATS	1.00%
WILYY Demant A/S	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALGN Align Technology	20,945	72.49 million	72.01 million	Optionable
ENOV Enovis	7,367	57.12 million	55.58 million	Optionable
SNN Smith & Nephew SNATS	17,349	437.97 million	433.59 million	Optionable
WILYY Demant A/S	22,639	427.59 million	N/A	Not Optionable

WILYY, SNN, ENOV, and ALGN Headlines

Recent News About These Companies

Demant A/S (WILYY) Stock Price, Quote, News & Analysis - Seeking Alpha

June 28 at 2:37 PM | seekingalpha.com

Demant A/S (OTCMKTS:WILYY) Raised to Hold at Barclays

June 23, 2025 | americanbankingnews.com

Demant A/S (OTCMKTS:WILYY) Upgraded at Barclays

June 21, 2025 | marketbeat.com

Demant A/S: Demant to acquire KIND and significantly expand the Group's hearing care footprint

June 11, 2025 | finanznachrichten.de

Demant A/S (OTCMKTS:WILYY) Stock Rating Upgraded by Citigroup

June 6, 2025 | marketbeat.com

Demant price target lowered to DKK 310 from DKK 325 at Morgan Stanley

May 14, 2025 | msn.com

Ruahei Demant: Black Ferns 'don't have as many outside distractions as 2022'

May 9, 2025 | rugbypass.comR

Demant A/S: Revised financial outlook for 2025 and Interim Management Statement for Q1 2025

May 6, 2025 | finanznachrichten.de

Is Demant (WILYY) Stock Undervalued Right Now?

April 28, 2025 | zacks.com

Kepler Capital Sticks to Its Hold Rating for Demant (WILLF)

April 24, 2025 | markets.businessinsider.com

Demant price target lowered to DKK 325 from DKK 345 at Morgan Stanley

April 8, 2025 | markets.businessinsider.com

Demant price target raised to DKK 290 from DKK 285 at Deutsche Bank

February 14, 2025 | markets.businessinsider.com

Demant price target lowered to DKK 345 from DKK 360 at Morgan Stanley

February 11, 2025 | markets.businessinsider.com

Demant (WILLF) Receives a Hold from Jefferies

February 7, 2025 | markets.businessinsider.com

Demant price target lowered to DKK 306 from DKK 319 at JPMorgan

February 7, 2025 | markets.businessinsider.com

Demant A/S Earnings Call: Mixed Sentiments Amid Growth

February 6, 2025 | tipranks.com

Demant projects 3%-7% organic revenue growth and DKK4.5B-DKK4.9B EBIT for 2025

February 6, 2025 | msn.com

Demant A/S Reports 2024 Financial Highlights and Strategic Focus

February 5, 2025 | tipranks.com

Demant A/S Reports Solid Growth and Strategic Focus in 2024

February 5, 2025 | tipranks.com

Demant A/S (WILLF) Q4 2024 Earnings Call Transcript

February 5, 2025 | seekingalpha.com

Demant shares drop on soft revenue dynamics

February 5, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

WILYY, SNN, ENOV, and ALGN Company Descriptions

Align Technology NASDAQ:ALGN

$194.28 +4.95 (+2.61%)

Closing price 04:00 PM Eastern

Extended Trading

$194.24 -0.03 (-0.02%)

As of 07:07 PM Eastern

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Enovis NYSE:ENOV

$32.99 +1.63 (+5.20%)

Closing price 03:59 PM Eastern

Extended Trading

$33.02 +0.03 (+0.09%)

As of 07:18 PM Eastern

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware.

Smith & Nephew SNATS NYSE:SNN

$30.59 -0.04 (-0.13%)

Closing price 03:59 PM Eastern

Extended Trading

$30.60 +0.02 (+0.05%)

As of 06:46 PM Eastern

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Demant A/S OTCMKTS:WILYY

$21.31 0.00 (0.00%)

As of 06/27/2025

Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare and Communications. The Hearing Healthcare segment is involved in the manufacturing, servicing, and sale of hearing aids, and diagnostic products and services. The Communications segment provides headsets and solutions for the professional call centers, office markets, and gaming markets under the EPOS brand name. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time